AN IMMUNE MODULATORY VACCINE TARGETING CCL22 PROMOTES ANTI-TUMOR IMMUNITY

被引：0
|
作者：
Lecoq, I. [1 ]
Kopp, K. L. [1 ]
Christensen, R. [1 ]
Martinenaite, E. [1 ,2 ]
Pedersen, A. W. [1 ]
Andersen, M. H. [1 ,2 ]
机构：
[1] IO Biotech, Copenhagen, Denmark
[2] Ctr Canc Immunotherapy, Copenhagen, Denmark
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-ITOC7.107
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P09.07
引用
收藏
页码：A55 / A55
页数：1
相关论文
共 50 条
  • [31] Affinity-coupled CCL22 promotes positive selection in germinal centres
    Liu, Bo
    Lin, Yihan
    Yan, Jiacong
    Yao, Jiacheng
    Liu, Dan
    Ma, Weiwei
    Wang, Jianbin
    Liu, Wanli
    Wang, Chengshuo
    Zhang, Luo
    Qi, Hai
    NATURE, 2021, 592 (7852) : 133 - 137
  • [32] Affinity-coupled CCL22 promotes positive selection in germinal centres
    Bo Liu
    Yihan Lin
    Jiacong Yan
    Jiacheng Yao
    Dan Liu
    Weiwei Ma
    Jianbin Wang
    Wanli Liu
    Chengshuo Wang
    Luo Zhang
    Hai Qi
    Nature, 2021, 592 : 133 - 137
  • [33] circ_0004140 promotes LUAD tumor progression and immune resistance through circ_0004140/miR-1184/CCL22 axis
    Liu, Yanyan
    Zhang, Haodong
    Zhang, Wangli
    Xiang, Lanxin
    Yin, Zhucheng
    Xu, Hongli
    Lu, Ping
    Ma, Yifei
    Xiong, Lingyi
    Zhang, Xiangchen
    Liang, Xin
    Luo, Jing
    Liang, Xinjun
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [34] Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
    Daniel S. Leventhal
    Anna Sokolovska
    Ning Li
    Christopher Plescia
    Starsha A. Kolodziej
    Carey W. Gallant
    Rudy Christmas
    Jian-Rong Gao
    Michael J. James
    Andres Abin-Fuentes
    Munira Momin
    Christopher Bergeron
    Adam Fisher
    Paul F. Miller
    Kip A. West
    Jose M. Lora
    Nature Communications, 11
  • [35] Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
    Leventhal, Daniel S.
    Sokolovska, Anna
    Li, Ning
    Plescia, Christopher
    Kolodziej, Starsha A.
    Gallant, Carey W.
    Christmas, Rudy
    Gao, Jian-Rong
    James, Michael J.
    Abin-Fuentes, Andres
    Momin, Munira
    Bergeron, Christopher
    Fisher, Adam
    Miller, Paul F.
    West, Kip A.
    Lora, Jose M.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [36] MACROPHAGES AND ANTI-TUMOR IMMUNITY
    SIMAR, LJ
    BONIVER, J
    COURTOY, R
    JOURNAL DE MICROSCOPIE ET DE BIOLOGIE CELLULAIRE, 1975, 23 (02): : A78 - A78
  • [37] Early Detection of Tumor Cells by Innate Immune Cells Leads to Treg Recruitment through CCL22 Production by Tumor Cells
    Faget, Julien
    Biota, Cathy
    Bachelot, Thomas
    Gobert, Michael
    Treilleux, Isabelle
    Goutagny, Nadege
    Durand, Isabelle
    Leon-Goddard, Sophie
    Blay, Jean Yves
    Caux, Christophe
    Menetrier-Caux, Christine
    CANCER RESEARCH, 2011, 71 (19) : 6143 - 6152
  • [38] Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environment
    Menetrier-Caux, Christine
    Faget, Julien
    Biota, Cathy
    Gobert, Michael
    Blay, Jean-Yves
    Caux, Christophe
    ONCOIMMUNOLOGY, 2012, 1 (05): : 759 - 761
  • [39] Non-viable tumor vaccine cells inhibit the generation of anti-tumor immunity
    Tran, AC
    Lin, A
    Borellini, F
    CANCER GENE THERAPY, 2000, 7 (12) : S23 - S23
  • [40] Enhanced anti-tumor immunity generated by Rituximab-coated tumor cell vaccine
    Wang, Huili
    Wang, Dongmei
    Li, Mengqiang
    Zhou, Chunxia
    Ma, Wenbo
    Su, Xiaosan
    Liu, Rongzhi
    Zhang, Shuren
    CANCER LETTERS, 2008, 268 (01) : 129 - 136
12345